5月份,一個充滿溫馨與感恩的季節,凡事以母為本,得以紮根向上向外穩健地拓展;台灣藥學國際合作中心 (TPIC),本年度投稿2016 FIP三篇文章:1)台灣產業藥學在整合醫藥學之爭論與進展,2) 台北市西藥商業同業公會 (TPBA) 的後藥學教育與永續發展之展望,3) 台灣推動自我照護的政策研商進程。皆在進入5/1勞動節前夕 — 4/28晚上,一個令人振奮人心的夜晚,我們收到世界藥學大會總部(FIP HQ)來信:三篇全數通過並受邀刊登完整篇幅的壁報論文,於2016.8.28-9.1在阿根廷舉行的2016 FIP盛會,與世界各國分享台灣產業藥學各方面的特色與政策研商進程,作為國際藥學政策施行的參考依據。

  • 以下是三篇受邀刊登證明:

Pharmaceutical Practice Industrial Pharmacy FIPSUB-1389

Integrative Medicine/Pharmacy Debated Issues and Progression in Taiwan Industrial Pharmacy

Chun-Yu (Mary) Wang1, 2, Ming-Sheng (Maxwell) Liang3, 4, 5, Ching-Yi Hsu* 6, 7

1Convener, Taiwan Pharmacy International Collaboration Center (TPIC), 2Director of Pharmacy Department, Shin Kong Hospital, 3Chief Executive Director, Taiwan Pharmacy International Collaboration Center (TPIC), 4President, Convener of Post Education of Industrial Pharmacy, Taipei Pharmaceutical Business Association, 5Honorary President, Taiwan Pharmaceutical Marketing and Management Association, 6Deputy General Secretary, Taiwan Pharmacy International Collaboration Center, 7Supervisor, Taipei Pharmaceutical Business Association, Taipei City, Taiwan, Republic of China

圖片2

Pharmaceutical Practice Industrial Pharmacy FIPSUB-1391

An Outlook for Sustainable Development and Post-Education (PE) of Industrial Pharmacy (IP) in Taipei Pharmaceutical Business Association (TPBA)

Ming-Sheng (Maxwell) Liang1, 2, 3, 4, Chun-Hao Lin5, Chih-Yuan Hsieh6, Yao Kun Cheng7, Liang-Meng Yang7, Tsai-Lien Ko Lee8, Chiu-Chun Lin9, Yi-Fen Chen10, Ya-Jan Chan11, Ching-Yi Hsu* 12, 13

1President, Convener of Post Education of Industrial Pharmacy, Taipei Pharmaceutical Business Association (TPBA), 27th-8th President, Taipei Pharmaceutical Agents and Distributors Association (TPADA), 311th-12th President, Taiwan Pharmaceutical Marketing and Management Association (TPMMA), 4Chief Executive Director, Taiwan Pharmacy International Collaboration Center, 5Honorary President of TPBA, 6Convener of TPBA Supervisory Committee, 7Standing Director of TPBA, 8Director of Executive Committee, Social Issue Publication Committee, 9Supervisor of Executive Committee, Director of Pharmaceutical Regulatory Committee, 10Director of Executive Committee, OTC Committee , 11General Secretary, Board of Secretariat, Taipei Pharmaceutical Business Association (TPBA), 12Supervisor of Executive Committee, Taipei Pharmaceutical Business Association, 13Deputy General Secretary, Taiwan Pharmacy International Collaboration Center, Taipei City, Taiwan, Republic of China

圖片3

Pharmaceutical Practice Industrial Pharmacy FIPSUB-1392

The Progression and Policy Discussion of Self-Medication in Taiwan

Ming-Sheng (Maxwell) Liang1, 2, 3, 4, Mau-Nan Chu5, Li-Cheng Shen6, I-Fang Tsai7, 8, Yi-Fen Chen9, 10, Chun-Yu (Mary) Wang11, 12, Ching-Yi Hsu* 13, 14

1Chief Executive Director, Taiwan Pharmacy International Collaboration Center (TPIC), 2Honorary President, Taiwan Pharmaceutical Marketing and Management Association (TPMMA), 3President, Convener of Post Education of Industrial Pharmacy, Taipei Pharmaceutical Business Association (TPBA), 47th-8th President, Taipei Pharmaceutical Agents and Distributors Association (TPADA), 5President of TPMMA, 6Standing Director of TPMMA Board meeting, OTC Executive Committee, 7Diretor of OTC Executive Committee, Taiwan Pharmaceutical Marketing and Management Association (TPMMA), 8Director of APSMI Board meeting, Asia-Pacific Self-medication Industry (APSMI) , 9Standing Director, Taiwan Pharmaceutical Marketing and Management Association (TPMMA), 10Director of Executive Committee, OTC Committee, Taipei Pharmaceutical Business Association (TPBA), 11Convener, Taiwan Pharmacy International Collaboration Center, 12Director of Pharmacy Department, Shin Kong Hospital, 13Deputy General Secretary, Taiwan Pharmacy International Collaboration Center, 14Supervisor of Executive Committee, Taipei Pharmaceutical Business Association (TPBA), Taipei City, Taiwan, Republic of China

圖片4

 

留言

Please enter your comment!
Please enter your name here

這個網站採用 Akismet 服務減少垃圾留言。進一步瞭解 Akismet 如何處理網站訪客的留言資料